Description: DisperSol Technologies provides expertise in formulation and processing technologies for solubility/bioavailability enhancement of poorly water-soluble drug molecules. DisperSol possesses a unique portfolio of technologies for the production of solubility enhanced systems that includes DisperSol’s proprietary KinetiSol™ technology. As a non-solvent, fusion-based process that minimizes thermal stress with highly efficient mixing, KinetiSol™ is uniquely positioned to generate amorphous solid dispersion systems with the most challenging APIs and with the broadest spectrum of pharmaceutical polymers. DisperSol has established a rapid KinetiSol™ feasibility program whereby the applicability of the process to any NCE can be determined rapidly and with relatively little API. Following a successful KinetiSol™ feasibility program, DisperSol is positioned to provide formulations development and manufacturing services to support clinical studies at all phases.
Business Profile
